Although hardly considered in clinical periodontitis studies, anti-inflammatory agents such as anti-TNF-α infliximab, used in for instance rheumatoid arthritis, were shown to have a stabilizing effect on the periodontal status of patients [48]. This evidence concerns the gene TNF and periodontitis.